DRIO logo

DarioHealth (DRIO) Company Overview

Profile

Full Name:

DarioHealth Corp.

Sector:

Healthcare

Country:

United States

IPO:

March 14, 2016

Indexes:

Not included

Description:

DarioHealth (DRIO) is a digital health company that offers personalized solutions for managing chronic conditions like diabetes. Their platform provides tools for monitoring health, accessing data, and receiving support, helping users improve their well-being and make informed decisions about their health.

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 18, 2019

Analyst ratings

Recent major analysts updates

Apr 1, 24 Stifel
Buy
Aug 11, 23 Alliance Global Partners
Buy
Jul 25, 23 Stifel
Buy
May 12, 23 Craig-Hallum
Buy
Nov 16, 22 Alliance Global Partners
Buy
Aug 18, 22 Aegis Capital
Buy
Aug 16, 22 Cowen & Co.
Outperform
May 16, 22 Cowen & Co.
Outperform
May 16, 22 Aegis Capital
Buy
May 13, 22 Alliance Global Partners
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market
DRIO
businesswire.comFebruary 7, 2025

NEW YORK--(BUSINESS WIRE)---- $DRIO #AI--Market News Alerts Updates: DarioHealth Corp. (Nasdaq: DRIO)* has announced a significant new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a pivotal expansion in the fast-growing digital health landscape. This move integrates Dario's AI-driven cardiometabolic digital health solutions, covering diabetes, hypertension, and weight management, into the offerings of one of America's most trusted health insurers. According to a recent report, the card.

PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation
DRIO
businesswire.comJanuary 30, 2025

NEW YORK--(BUSINESS WIRE)---- $DRIO #GLP1--PESG Releases Report: In a healthcare market brimming with potential, DarioHealth Corp. (Nasdaq: DRIO)* is quietly emerging as a standout player, combining cutting-edge technology with proven outcomes. Looking at recent achievements, it seems DarioHealth's multi-condition digital health platform and its accelerating financial trajectory may position it as a sleeper hit in a rapidly growing sector. Breaking Down the Opportunity At the heart of DarioHealth's success is.

DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025
DRIO
prnewswire.comJanuary 21, 2025

Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy Financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring revenues across B2B (Business-to-Business) and pharma channels NEW YORK , Jan. 21, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a prominent leader in the global digital health industry, announced today the successful closing of a $25.6 million private placement of convertible preferred stock, priced in accordance with Nasdaq market rules. The majority of the funds were secured from existing shareholders, with the remainder contributed by a network of leading accredited healthcare investors and executives from the healthcare sector.

DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets
DRIO
prnewswire.comJanuary 14, 2025

New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications, opening new revenue streams in direct-to-consumer and pharma channels NEW YORK , Jan. 14, 2025 /PRNewswire/ -- January 14, 2025 -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a collaboration with MediOrbis, a multi-specialty digital health provider, to add prescribing capabilities to Dario's GLP-1 behavior change solution for a comprehensive medical weight loss program. This strategic addition creates a fully integrated solution for employers covering weight-loss medications and supports direct-to-consumer offerings, expanding Dario's addressable market in one of the fastest-growing segments of digital health.

DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market
DRIO
businesswire.comJanuary 14, 2025

NEW YORK--(BUSINESS WIRE)--Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company's latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers. Following the announcement, Dario's shar.

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript
DRIO
seekingalpha.comNovember 9, 2024

DarioHealth Corp. (NASDAQ:DRIO ) Q3 2024 Results Conference Call November 7, 2024 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Third Quarter 2024 Results Call. [Operator Instructions] This call is being recorded on November 7, 2024.

DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DarioHealth Corp. (DRIO) Reports Q3 Loss, Tops Revenue Estimates
DRIO
zacks.comNovember 7, 2024

DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.49 per share a year ago.

Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
Dario Signs New Regional Health Plan, Expanding Reach in Medicaid Population
DRIO
prnewswire.comOctober 30, 2024

The new contract marks the eighth health plan for Dario and will contribute to revenues starting immediately. NEW YORK , Oct. 30, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract with a regional health plan in the Medicaid space, which has launched with the full suite of cardiometabolic solutions.

DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DarioHealth to Report Third Quarter 2024 Results on Thursday, November 7th
DRIO
prnewswire.comOctober 23, 2024

Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 23, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a global leader in digital health, announced today that it will release its financial results for the 3rd quarter ended September 30th, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Thursday, November 7th, 2024, before the market opens.     Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call.

Twill by Dario to Offer a Benefit for AARP Members
Twill by Dario to Offer a Benefit for AARP Members
Twill by Dario to Offer a Benefit for AARP Members
DRIO
prnewswire.comOctober 15, 2024

New offer gives Dario access to millions of AARP members, enabling engagement with people over 50 in health and well-being beginning in January 2025 NEW YORK , Oct. 15, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new AARP member benefit that provides members with proven digital behavioral health and well-being solutions from Twill by Dario. The new benefit is expected to launch in January of 2025 for AARP members.

  • 1(current)
  • 2
  • 3
  • 1(current)
  • 2
  • 3

FAQ

  • What is the ticker symbol for DarioHealth?
  • Does DarioHealth pay dividends?
  • What sector is DarioHealth in?
  • What industry is DarioHealth in?
  • What country is DarioHealth based in?
  • When did DarioHealth go public?
  • Is DarioHealth in the S&P 500?
  • Is DarioHealth in the NASDAQ 100?
  • Is DarioHealth in the Dow Jones?
  • When was DarioHealth's last earnings report?
  • When does DarioHealth report earnings?
  • Should I buy DarioHealth stock now?

What is the ticker symbol for DarioHealth?

The ticker symbol for DarioHealth is NASDAQ:DRIO

Does DarioHealth pay dividends?

No, DarioHealth does not pay dividends

What sector is DarioHealth in?

DarioHealth is in the Healthcare sector

What industry is DarioHealth in?

DarioHealth is in the Health Information Services industry

What country is DarioHealth based in?

DarioHealth is headquartered in United States

When did DarioHealth go public?

DarioHealth's initial public offering (IPO) was on March 14, 2016

Is DarioHealth in the S&P 500?

No, DarioHealth is not included in the S&P 500 index

Is DarioHealth in the NASDAQ 100?

No, DarioHealth is not included in the NASDAQ 100 index

Is DarioHealth in the Dow Jones?

No, DarioHealth is not included in the Dow Jones index

When was DarioHealth's last earnings report?

DarioHealth's most recent earnings report was on Nov 7, 2024

When does DarioHealth report earnings?

The next expected earnings date for DarioHealth is Mar 28, 2025

Should I buy DarioHealth stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions